Advertisements

Roche drug cocktail doubles chance of holding lung cancer at bay

Roche drug cocktail doubles chance of holding lung cancer at bay.....»»

Category: topSource: business-standardDec 7th, 2017

US STOCKS-Industrials, techs lift Wall St, health stocks limit gains

US STOCKS-Industrials, techs lift Wall St, health stocks limit gains.....»»

Category: marketsSource: sifyNov 20th, 2017

US STOCKS-Tech stocks help Wall Street higher

US STOCKS-Tech stocks help Wall Street higher.....»»

Category: economySource: sifyNov 20th, 2017

Roche win boosts case for adding chemo to cancer immunotherapy

Roche win boosts case for adding chemo to cancer immunotherapy.....»»

Category: global-financeSource: business-standardNov 20th, 2017

Intas Pharmaceuticals Brings Down Cancer Treatment Cost by 60%

Intas Pharmaceuticals Brings Down Cancer Treatment Cost by 60%.....»»

Category: topSource: moneycontrolOct 5th, 2017

Novartis" skin cancer drug posts win in trials, Roche flops

Novartis" skin cancer drug posts win in trials, Roche flops.....»»

Category: global-financeSource: business-standardSep 11th, 2017

AstraZeneca rebuilds cancer drug hopes with new lung data

AstraZeneca rebuilds cancer drug hopes with new lung data.....»»

Category: global-financeSource: reutersSep 8th, 2017

Biocon drops after USFDA delays decision on biosimilar

Biocon drops after USFDA delays decision on biosimilar.....»»

Category: topSource: business-standardAug 31st, 2017

FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer

FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer.....»»

Category: press-releasesSource: businesswireindiaAug 9th, 2017

AstraZeneca Pharma gains 3% on plan to launch cancer drug in India

AstraZeneca Pharma gains 3% on plan to launch cancer drug in India.....»»

Category: topSource: moneycontrolJul 24th, 2017

Roche"s Tecentriq receives positive opinion from EU medicines agency

Roche"s Tecentriq receives positive opinion from EU medicines agency.....»»

Category: global-financeSource: reutersJul 22nd, 2017

INSIGHT: Beijing buyers club? China"s cancer patients gamble on grey market

INSIGHT: Beijing buyers club? China"s cancer patients gamble on grey market.....»»

Category: global-financeSource: reutersDec 25th, 2016

Roche"s emicizumab haemophilia drug succeeds in trial

Roche"s emicizumab haemophilia drug succeeds in trial.....»»

Category: global-financeSource: reutersDec 22nd, 2016

Centre questions maintainability of Roche’s plea against Cadilla’s cancer drug

Centre questions maintainability of Roche’s plea against Cadilla’s cancer drug.....»»

Category: featuresSource: livemintAug 29th, 2016

European shares advance as Roche rally lifts pharma stocks

European shares advance as Roche rally lifts pharma stocks.....»»

Category: economySource: sifyMay 27th, 2016

REFILE-European shares inch lower ahead of Yellen; Roche rallies

REFILE-European shares inch lower ahead of Yellen; Roche rallies.....»»

Category: marketsSource: sifyMay 27th, 2016

Roche faces setback on cancer drug biosimilar case in Delhi HC

Roche faces setback on cancer drug biosimilar case in Delhi HC.....»»

Category: featuresSource: livemintMay 20th, 2016

Delhi HC strikes down breast cancer biosimilars" approval for Roche drug

Delhi HC strikes down breast cancer biosimilars" approval for Roche drug.....»»

Category: featuresSource: business-standardApr 27th, 2016

Rhizen receives USFDA fast track designation for cancer drug

Rhizen receives USFDA fast track designation for cancer drug.....»»

Category: topSource: moneycontrolDec 11th, 2017

Biocon share price surges 15% on FDA nod for generic cancer drug

Biocon share price surges 15% on FDA nod for generic cancer drug.....»»

Category: marketsSource: thehindubusinesslineDec 4th, 2017

Biocon rallies over 14% on FDA approval for biosimilar version of Herceptin

Biocon rallies over 14% on FDA approval for biosimilar version of Herceptin.....»»

Category: marketsSource: thehindubusinesslineDec 4th, 2017